Skip to search formSkip to main contentSkip to account menu

Nortensin

Known as: Yohimban-16-carboxylic acid, 11,17-dimethoxy-18-((3,4,5-trimethoxybenzoyl)oxy)-, methyl ester, (3beta,16beta,17alpha,18beta,20alpha)-, mixt. with 5-(aminosulfonyl)-4-chloro-2-((2-furanylmethyl)amino)benzoic acid 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

Drug CombinationsFurosemideReserpine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1979
1979
[Management of hypertension in subjects with healthy metabolism and in diabetics. The new galenian furosemide-reserpine combinations Nortensin capsules and Nortensin mite capsules].
  • G. Carl
  • ZFA - Zeitschrift für Allgemeinmedizin
  • 1979
  • Corpus ID: 40201001
1974
1974
[Therapeutic experiences with Nortensin in the therapy of hypertension due to pregnancy].
1973
1973
[Continued treatment of hypertension with Nortensin].
1971
1971
[Saluretic treatment of hypertension. Experiences with furosemide-reserpine (Nortensin)].
1971
1971
[Therapy of the hypertensive symptom using Nortensin].
1971
1971
[Saluretic treatment of hypertension. Experiences with furosemide-reserpine (Nortensin)].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)